Apogee Therapeutics Inc
NASDAQ:APGE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
IHI Corp
TSE:7013
|
JP |
|
SITC International Holdings Co Ltd
OTC:SITIF
|
HK |
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
EDP Energias de Portugal SA
F:EDPA
|
PT |
|
A
|
Akamai Technologies Inc
XHAM:AK3
|
US |
Wall St Price Targets
APGE Price Targets Summary
Apogee Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for APGE is 137.22 USD with a low forecast of 132.31 USD and a high forecast of 141.87 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APGE's stock price target?
Price Target
137.22
USD
According to Wall Street analysts, the average 1-year price target for APGE is 137.22 USD with a low forecast of 132.31 USD and a high forecast of 141.87 USD.